97 related articles for article (PubMed ID: 19907326)
1. Thyroid tumorigenesis and molecular markers in thyroid cancer.
Kouniavsky G; Zeiger MA
Curr Opin Oncol; 2010 Jan; 22(1):23-9. PubMed ID: 19907326
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis.
Vasko VV; Saji M
Curr Opin Oncol; 2007 Jan; 19(1):11-7. PubMed ID: 17133106
[TBL] [Abstract][Full Text] [Related]
4. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
Carpi A; Mechanick JI; Saussez S; Nicolini A
J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
6. Genetic background of carcinogenesis in the thyroid gland.
Lewiński A; Wojciechowska K
Neuro Endocrinol Lett; 2007 Apr; 28(2):77-105. PubMed ID: 17435680
[TBL] [Abstract][Full Text] [Related]
7. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Douglas WG; Anderson GR; Stoler DL
Head Neck; 2003 Aug; 25(8):662-70. PubMed ID: 12884350
[TBL] [Abstract][Full Text] [Related]
9. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of prostate cancer: clinical translational opportunities.
Vecchione A; Gottardo F; Gomella LG; Wildemore B; Fassan Ms; Bragantini E; Pagano F; Baffa R
J Exp Clin Cancer Res; 2007 Mar; 26(1):25-37. PubMed ID: 17550130
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and growth factors in thyroid carcinogenesis.
Frauman AG; Moses AC
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid cancer: therapeutic targets and molecular markers.
Ball DW
Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
[TBL] [Abstract][Full Text] [Related]
13. [Cellular tumor markers in thyroid cancer].
Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
[TBL] [Abstract][Full Text] [Related]
14. [Fetal cell carcinogenesis hypothesis and its impact on clinical pathology of cancer].
Takano T
Rinsho Byori; 2008 May; 56(5):402-8. PubMed ID: 18546890
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
16. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinoma.
Wiseman SM; Griffith OL; Gown A; Walker B; Jones SJ
Am J Surg; 2011 May; 201(5):580-6. PubMed ID: 21545903
[TBL] [Abstract][Full Text] [Related]
18. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
19. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of thyroid nodules and cancer.
Moretti F; Nanni S; Pontecorvi A
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
